Market Overview

Benzinga's Top Upgrades

Share:
Related AGN
Pfizer's $1.5 Billion Antibiotics Buy: Strategic Long-Term Planning Or Pre-Split Prep?
Pfizer Has Had A Busy M&A Year...Or Has It?
Candidate Clinton's harsh comments on high price of Mylan's EpiPen sends biotechs reeling; IBB down 2% (Seeking Alpha)
Related STR
A Seasoned Dividend ETF Tries To Get Its Groove Back
Earnings Scheduled For February 17, 2016

Analysts at CLSA upgraded Allergan (NYSE: AGN) from “underperform” to “outperform.” Allergan's shares closed at $91.50 on Friday. Allergan's trailing-twelve-month revenue is $5.61 billion.

Analysts at UBS upgraded Questar (NYSE: STR) from “neutral” to “buy.” Questar's stock closed at $19.37 on Friday. Questar's trailing-twelve-month operating margin is 33.27%.

Analysts at Goldman upgraded Rubicon Technology (NASDAQ: RBCN) from “sell” to “neutral.” Rubicon Technology's shares closed at $10.31 on Friday. Rubicon Technology's PEG ratio is -3.25.

Analysts at Deutsche Bank upgraded Cooper Tire & Rubber (NYSE: CTB) from “hold” to “buy.” Cooper Tire & Rubber's shares closed at $19.94 on Friday. Cooper Tire & Rubber's trailing-twelve-month operating margin is 6.03%.

Latest Ratings for AGN

DateFirmActionFromTo
Aug 2016Mizuho SecuritiesUpgradesNeutralBuy
Aug 2016Deutsche BankMaintainsBuy
Jul 2016Credit SuisseInitiates Coverage onOutperform

View More Analyst Ratings for AGN
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (AGN + CTB)

View Comments and Join the Discussion!